|
2025-06-16 |
2025-06-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
1,000
-0.5%
61.37
USD 24,548
|
1,000
-0.5%
|
61.37
|
USD 100,000
|
|
|
2025-05-16 |
2025-05-15 |
S
Sale
|
Gutwerg Ori
SVP, GENERICS
Officer
|
881
-1.0%
60.07
USD 52,922
|
881
-1.0%
|
60.07
|
USD 52,922
|
|
|
2025-05-15 |
2025-05-14 |
S
Sale
|
Mutz Christopher
HEAD OF RARE DISEASE
Officer
|
4,000
-3.6%
60.45
USD 241,800
|
4,000
-3.6%
|
60.45
|
USD 241,800
|
|
|
2025-05-13 |
2025-05-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
400
-0.5%
62.20
USD 24,880
|
400
-0.5%
|
62.20
|
USD 24,880
|
|
|
2025-05-13 |
2025-05-09 |
PS
Planned sale
|
Shanmugam Muthusamy
HEAD OF R&D, COO-NOVITIUM OPS
Executive Director
|
700
-0.1%
76.83
USD 53,781
|
700
-0.1%
|
76.83
|
USD 53,781
|
|
|
2025-04-14 |
2025-04-14 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
400
-0.5%
68.96
USD 27,584
|
400
-0.5%
|
68.96
|
USD 27,584
|
|
|
2025-03-20 |
2025-03-19 |
PS
Planned sale
|
Davis Krista
SVP, CHIEF HR OFFICER
Officer
|
1,866
-2.8%
65.00
USD 121,290
|
1,866
-2.8%
|
65.00
|
USD 121,290
|
|
|
2025-03-14 |
2025-03-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
400
-0.5%
63.33
USD 25,332
|
400
-0.5%
|
63.33
|
USD 25,332
|
|
|
2025-03-10 |
2025-03-07 |
PS
Planned sale
|
Davis Krista
SVP, CHIEF HR OFFICER
Officer
|
1,000
-1.5%
60.86
USD 60,860
|
1,000
-1.5%
|
60.86
|
USD 60,860
|
|
|
2025-03-07 |
2025-03-05 |
S
Sale
|
Gutwerg Ori
SVP, GENERICS
Officer
|
5,084
-5.1%
60.00
USD 305,040
|
5,084
-5.1%
|
60.00
|
USD 305,040
|
|
|
2025-03-07 |
2025-03-05 |
S
Sale
|
Gutwerg Ori
SVP, GENERICS
Officer
|
300
-0.3%
60.03
USD 18,009
|
300
-0.3%
|
60.03
|
USD 18,009
|
|
|
2025-02-24 |
2025-02-21 |
PS
Planned sale
|
Davis Krista
SVP, CHIEF HR OFFICER
Officer
|
1,000
-1.4%
60.20
USD 60,200
|
1,000
-1.4%
|
60.20
|
USD 60,200
|
|
|
2025-02-18 |
2025-02-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
400
-0.5%
59.54
USD 23,816
|
400
-0.5%
|
59.54
|
USD 23,816
|
|
|
2025-01-13 |
2025-01-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
400
-0.7%
53.92
USD 21,568
|
400
-0.7%
|
53.92
|
USD 21,568
|
|
|
2024-12-18 |
2024-12-17 |
S
Sale
|
CAREY STEPHEN P.
SVP & CFO
Officer
|
7,500
-4.6%
55.79
USD 418,425
|
7,500
-4.6%
|
55.79
|
USD 418,425
|
|
|
2024-12-16 |
2024-12-13 |
PS
Planned sale
|
Cook Meredith
SR. VP, GENERAL COUNSEL & SEC.
Officer
|
250
-0.4%
56.24
USD 14,060
|
250
-0.4%
|
56.24
|
USD 14,060
|
|
|
2024-12-12 |
2024-12-11 |
PS
Planned sale
|
Davis Krista
SVP, CHIEF HR OFFICER
Officer
|
1,000
-2.0%
60.00
USD 60,000
|
1,000
-2.0%
|
60.00
|
USD 60,000
|
|
|
2024-11-27 |
2024-11-26 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
3,481
-0.9%
58.30
USD 202,942
|
3,481
-0.9%
|
58.30
|
USD 202,942
|
|
|
2024-11-27 |
2024-11-26 |
S
Sale
|
Lalwani Nikhil
PRESIDENT & CEO
Executive Director
|
30,000
-7.4%
57.95
USD 1,738,500
|
30,000
-7.4%
|
57.95
|
USD 1,738,500
|
|
|
2024-11-18 |
2024-11-15 |
S
Sale
|
Mutz Christopher
HEAD OF RARE DISEASE
Officer
|
6,500
-7.8%
57.70
USD 375,050
|
6,500
-7.8%
|
57.70
|
USD 375,050
|
|
